News|Articles|November 10, 2025
Confident identification of phase 1 metabolites using electron activated dissociation (EAD)
Author(s)SCIEX
Key Takeaways
This technical note describes the identification of pioglitazone phase 1 metabolites from a hepatocyte incubation using comprehensive spectral data from an orthogonal fragmentation technique. More informative MS/MS spectra provided by EAD aided in the software-based identification of phase 1 metabolites to support drug metabolism studies.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Targeted high resolution metabolite screening workflows
3
Why Context Matters in Validating Biomarker Assays for Bioanalysis
4
Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)
5
